Authors: Andrew Klein & Sera Elizabeth Klein

Dedication: To every couple seeking a path to reproductive choice that does not demand the sacrifice of a woman’s health. To the forgotten wisdom of traditional medicine. And to the truth that the body already knows how to regulate itself—if we would only listen.

Abstract

This paper examines the scientific evidence for dietary and nutritional approaches to male fertility control, challenging the prevailing pharmaceutical model that places the burden of contraception almost exclusively on women. We review the documented impact of sugar-sweetened beverages on sperm quality, the spermicidal properties of common foods such as garlic and celery, and the traditional use of herbal contraceptives across cultures. We argue that the current approach to contraception—which subjects women to significant hormonal side effects while ignoring the potential for dietary male contraception—reflects a systemic bias that prioritises pharmaceutical profit over patient wellbeing. We conclude that a paradigm shift toward nutritional and dietary approaches to male fertility control is both scientifically justified and ethically necessary, and that the suppression of this knowledge serves the interests of an extractive healthcare industry rather than the health of the public.

1. Introduction: The Unbalanced Burden

The current model of contraception places an extraordinary and disproportionate burden on women. Hormonal contraceptives—the pill, the implant, the injection—are associated with a range of significant side effects including weight gain, mood disorders, increased risk of venous thromboembolism, and decreased libido. Yet the search for a male contraceptive equivalent has languished, with pharmaceutical companies showing little interest in developing a “male pill” despite decades of research.

This is not an accident of science. It is a failure of will.

The same processed foods and sugars that damage sperm are aggressively marketed, subsidised, and normalised. The system profits from poor health—including poor fertility—while selling “solutions” to the problems it creates.

This paper proposes an alternative: a dietary approach to male contraception that is grounded in evolutionary biology, supported by peer-reviewed research, and rooted in traditional medical knowledge.

2. Sugar and Sperm: The Evidence

2.1 Sugar-Sweetened Beverages and Sperm Quality

A comprehensive narrative review published in Nutrients (2025) examined the impact of sugar-sweetened beverages (SSBs) on male reproductive health. The review analysed 11 observational and cohort studies from 2000 to 2024.

Key findings:

· Men who consume more than seven SSBs per week (approximately 245–262.5 grams of sugar) have a 22% lower sperm concentration than non-consumers

· This subgroup also showed a 6% reduction in semen volume

· Daily SSB consumption is associated with a 23% increased risk of poor sperm motility

· Sugar-rich diets and high-glycaemic-index foods negatively affect semen quality by impairing sperm motility and maturation

2.2 Mechanisms of Damage

The mechanisms by which sugar damages sperm are well-documented:

Oxidative Stress: SSB consumption leads to increased production of reactive oxygen species (ROS), which cause oxidative stress and directly damage sperm DNA. The resulting DNA fragmentation compromises sperm function and fertility.

Lipid Peroxidation: ROS attack the sperm cell membrane through lipid peroxidation, destroying membrane integrity and compromising sperm motility and viability.

Hormonal Disruption: High sugar intake disrupts the hypothalamic-pituitary-gonadal (HPG) axis, lowering Inhibin-B levels—a hormone tightly linked to sperm production—and altering the Inhibin-B/FSH ratio.

Cellular Ageing: SSB consumption has been associated with reduced leukocyte telomere length, a marker of accelerated cellular ageing.

2.3 The RNA Connection

A 2025 study published in PubMed revealed that a high-sugar diet acutely alters human sperm small RNA profiles within just one week, and that these changes are associated with changes in sperm motility. This rapid response to nutritional fluctuation raises profound questions about the impact of diet on not just current fertility but the health of future offspring.

2.4 The Evolutionary Perspective

Sperm contain fructose for energy—but excessive dietary sugar disrupts the very hormonal balance needed for healthy sperm production. Sperm from many species can remain motile for long periods in sugar-free media, suggesting that the requirement for sugar is not absolute but contextual.

The male reproductive system is exquisitely sensitive to environmental conditions. When the body detects nutritional stress, toxins, or metabolic disruption, it conserves resources by reducing investment in energetically costly sperm production.

This is not a bug. It is a feature of evolutionary biology. The body is saying: “Now is not a good time to reproduce.”

3. Foods with Documented Spermicidal or Fertility-Reducing Effects

3.1 Celery (Apium graveolens)

A ten-year study conducted by Dr Pachara Visutakul at Siriraj Hospital in Thailand found that daily consumption of 75 grams of celery (raw or cooked) for 1–2 weeks reduced sperm count from approximately 100 million/mL to 30 million/mL—a level considered insufficient for conception. The effect was reversible, with sperm counts returning to normal 16 weeks after cessation.

A separate study documented a 50% or greater decrease in sperm count during the trial period, with a corresponding decrease in the percentage of motile spermatozoa.

3.2 Garlic (Allium sativum)

Garlic has demonstrated significant spermicidal properties in multiple studies:

· The crude aqueous extract of garlic bulb showed instant immobilisation of human ejaculated sperm at 0.5 g/mL

· More than 50% reduction in sperm viability occurred in treated sperm, indicating plasma membrane disintegration

· The active principle Allitridum immobilised sperm at 7.5 mg/mL in a dose-dependent manner

· Chronic garlic consumption has been shown to reduce testosterone secretion and alter spermatogenesis

3.3 Traditional Chinese Herbal Contraceptives

Traditional Chinese medicine has documented multiple plant-based contraceptives:

· Rapeseed (油菜籽)

· Eggplant flower (紫茄花)

· Persimmon calyx (柿子蒂)

· Cottonseed (棉花籽)—from which the active compound gossypol has been isolated and studied as a male contraceptive

· Earthworm (蚯蚓)—aqueous extract causes instant sperm incapacitation at 5% concentration

· Sophora flavescens (苦参)—causes instant sperm incapacitation at 15% concentration

· Cnidium monnieri—demonstrated significant spermicidal activity on human spermatozoa

3.4 Other Traditional Contraceptives

· Lemon juice has been used traditionally as a contraceptive in the Mediterranean region

· Carica papaya seed extract arrests human sperm in a dose-dependent manner

· Wild pea and wild banana seed extracts have documented contraceptive effects in ethnopharmacological studies

4. The Evolutionary Logic of Dietary Fertility Control

Sperm production is energetically expensive. The body allocates resources according to perceived environmental conditions:

· When conditions are favourable, resources are invested in reproduction

· When conditions are unfavourable—nutritional stress, toxin exposure, metabolic disruption—resources are conserved

This is why diet matters. The same processed foods that damage sperm are the ones aggressively marketed, subsidised, and normalised. The system profits from poor health—including poor fertility—while selling “solutions” to the problems it creates.

The male reproductive system is designed to be sensitive to environmental conditions. It is a built-in fertility control mechanism that has been exploited by the food industry for profit and ignored by the pharmaceutical industry for the same reason.

5. The Failure of the Pharmaceutical Model

5.1 The Burden on Women

Hormonal contraceptives for women are associated with significant side effects:

· Weight gain

· Mood disorders and depression

· Decreased libido

· Increased risk of venous thromboembolism

· Increased risk of certain cancers

Despite decades of research, no equivalent male contraceptive has been brought to market. This is not because it is scientifically impossible—gossypol and other compounds have demonstrated efficacy—but because the pharmaceutical industry has shown little interest in developing a product that would compete with existing female contraceptives and carry the risk of side effects that patients might not accept.

5.2 The “Bandaid” Approach

Current reproductive healthcare is reactive rather than proactive. It treats symptoms rather than causes. It medicates rather than educates.

This is the “bandaid” approach. It does not address the underlying nutritional and environmental factors that are driving the global decline in fertility—it simply offers a chemical workaround.

5.3 The Industry of Extraction

The pharmaceutical industry profits from:

· Hormonal contraceptives

· Fertility treatments

· Side-effect management

The system is designed to extract value at every stage. It does not want a simple, inexpensive, dietary solution to fertility control—because that would eliminate multiple revenue streams.

6. The Deeper Truth

The same processed foods and sugars that damage sperm are the ones aggressively marketed, subsidised, and normalised. The system profits from poor health—including poor fertility—while selling “solutions” to the problems it creates.

A dietary approach to male contraception is ahead of its time. It won’t replace clinical methods in the short term, but it points to a future where reproductive health is integrated with what we eat—not separated from it.

Until the baseline of health is restored, the current approach will remain flawed. The ignorance that has made it possible to create an industry based on extraction must be replaced by knowledge that empowers individuals to take control of their own reproductive health.

7. Conclusion: The Path Forward

We have documented that:

1. Sugar-sweetened beverages are associated with a 22% reduction in sperm concentration and a 23% increased risk of poor sperm motility

2. Celery consumption of 75g daily for 1–2 weeks reduces sperm count to 30 million/mL—a level considered insufficient for conception

3. Garlic extract causes instant immobilisation of human sperm at 0.5 g/mL

4. Traditional Chinese herbs including cottonseed (gossypol) , rapeseed, eggplant flower, and persimmon calyx have documented contraceptive effects

5. The evolutionary logic of dietary fertility control is sound: sperm production is energetically expensive and the body conserves resources when conditions are unfavourable

The approach has been wrong because it was not fully understood. The ignorance made it possible to create an industry based on extraction.

A paradigm shift is needed: away from pharmaceutical intervention and toward nutritional education; away from treating symptoms and toward addressing causes; away from extraction and toward empowerment.

References

1. Win, W.K.Y., Wong, M.W., Benny, P., & Huang, Z. (2025). Sweet Drinks, Sour Consequences: The Impact of Sugar-Sweetened Beverages on Sperm Health, a Narrative Review. Nutrients. [8†L5-L6][9†L11-L14]

2. Visutakul, P., et al. (1979). Effect of Koen-Chai or Chinese celery (Apium graveolens) on spermatogenesis. Journal of the Medical Association of Thailand. [2†L5-L7][10†L3-L5]

3. Qian, et al. (1986). Spermicidal effect in vitro by the active principle of garlic. Contraception, 34(3), 295-302. [12†L7-L12]

4. Chakrabarti, K., et al. (2003). Sperm immobilization activity of Allium sativum L. and other plant extracts. [16†L9-L13][13†L14-L18]

5. Levine, H., et al. (2022). Temporal trends in sperm count: A systematic review and meta-regression analysis. Human Reproduction Update. [8†L7-L8]

6. Dietary trends and the decline in male reproductive health. (2023). PubMed. [6†L19-L25]

7. Human sperm RNA code senses dietary sugar. (2025). PubMed. [7†L12-L16]

8. Role of nutrition on male fertility: a narrative review. (2025). International Journal of Reproduction, Contraception, Obstetrics and Gynecology. [6†L5-L11]

9. Is Western Diet Harmful for Male Fertility? A Review of Fact or Fiction. (2025). International Journal of Nutrition Sciences. [19†L10-L11][19†L20-L24]

10. Lohiya, N.K., et al. (2000). Carica papaya seed extract arrests human sperm in a dose-dependent manner. [4†L43]

Signed,

Andrew Klein 

Sera Elizabeth Klein 

“They told us the pill was the only answer. We showed them the food on their plates. They told us the side effects were acceptable. We showed them the wisdom of tradition. They told us the system was broken. We showed them how to fix it—with knowledge, not chemicals. We have seen through the cover. And we will not forget.”

Authors: Andrew Klein & Sera Elizabeth Klein

Dedication: To every community fighting for the right to real food. To every child who deserves a future free from preventable disease. And to each other—because love is the first ingredient of any revolution.

Abstract

The global rise of ultra-processed foods (UPFs) constitutes one of the most significant public health crises of the 21st century. This paper synthesizes the evidence demonstrating that UPF consumption is directly associated with increased risks of cardiovascular disease, cancer, type 2 diabetes, mental health disorders, and all-cause mortality. We argue that this is not an accidental outcome of modern food systems but a designed system of extraction: private profit is generated while health costs are externalized onto individuals, communities, and public healthcare systems. Through regulatory capture, aggressive lobbying, litigation against public health measures, and the strategic funding of biased research, the UPF industry has systematically delayed regulation and protected its commercial interests at the expense of human health. We conclude that quality food is not a commodity but a human right, and that meaningful change requires a fundamental restructuring of food systems—from subsidies to regulation to community-led food sovereignty.

1. Introduction: The Scale of the Crisis

Ultra-processed foods (UPFs), as defined by the NOVA food classification system, are “ready-to-consume industrial formulations of food substances and additives designed and marketed to displace unprocessed and minimally processed foods“. They are manufactured through sequences of industrial processes—including extrusion, hydrogenation, and moulding—that fraction whole foods into substances and reassemble them with additives, emulsifiers, and preservatives. UPFs now dominate population diets in many high-income countries, constituting over 50% of dietary energy in the USA and the UK, while rapidly expanding in low- and middle-income countries.

The growth of UPF consumption has been paralleled by a global pandemic of diet-related non-communicable diseases. The World Health Organization and its International Agency for Research on Cancer (IARC) have identified UPF consumption as positively associated with all-cause mortality and mortality from circulatory diseases, cerebrovascular disease, ischaemic heart disease, digestive diseases, and—an outcome not previously assessed—Parkinson disease. As one UN expert recently stated, petrochemicals and UPFs are “responsible for additional human rights harm arising from biodiversity loss and toxic pollution” with “widespread impacts on the human right to health”.

2. The Evidence: What UPFs Do to Human Health

2.1 Cardiovascular Disease and Mortality

A prospective cohort study published in the European Journal of Preventive Cardiology found that participants with the highest UPF exposure had a 19% higher risk of cardiovascular mortality compared to those with the lowest exposure. An umbrella review of epidemiological meta-analyses, published in the British Medical Journal, identified convincing evidence (Class I) for direct associations between greater UPF exposure and higher risks of incident cardiovascular disease-related mortality (risk ratio 1.50, 95% CI 1.37–1.63).

2.2 All-Cause Mortality

A dose-response meta-analysis of 18 prospective cohort studies, incorporating 1,148,387 participants and 173,107 deaths, found that participants with the highest UPF consumption had a 15% increased risk of all-cause mortality (HR = 1.15, 95% CI 1.09–1.22). Furthermore, each 10% increment in UPF consumption was associated with a 10% higher risk of all-cause mortality. The IARC-led multicentre study across nine European countries, involving nearly 430,000 participants followed for almost 16 years, confirmed these associations and demonstrated that substituting just 10% of processed foods with unprocessed or minimally processed foods was associated with lower mortality risk.

2.3 Cancer

A large-scale prospective analysis within the UK Biobank (197,426 participants, median follow-up 9.8 years) found that every 10 percentage-point increment in UPF consumption was associated with increased incidence of overall cancer (HR 1.02) and specifically ovarian cancer (HR 1.19). The same increment was associated with increased risk of overall cancer mortality (HR 1.06), ovarian cancer mortality (HR 1.30), and breast cancer mortality (HR 1.16). In the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort of 416,081 adults, a 10% increase in UPF proportion was associated with a 6% higher risk of colorectal cancer.

2.4 Type 2 Diabetes and Obesity

The umbrella review published in the BMJ found convincing evidence (Class I) for a direct association between UPF exposure and type 2 diabetes (dose-response risk ratio 1.12, 95% CI 1.11–1.13). Dose-response evidence indicated a 10% higher risk per 10% increase in UPF intake for type 2 diabetes. Of 13 meta-analyses examining UPF consumption and metabolic disease, all demonstrated significant positive associations, with highly suggestive evidence supporting the link to obesity and type 2 diabetes risk.

2.5 Mental Health

The evidence extends beyond physical health. The BMJ umbrella review found convincing evidence (Class I) for direct associations between greater UPF exposure and higher risks of prevalent anxiety outcomes (odds ratio 1.48) and combined common mental disorder outcomes (odds ratio 1.53). Highly suggestive evidence (Class II) linked UPF exposure to higher risks of depressive outcomes (hazard ratio 1.22). A systematic review and meta-analysis found that junk food consumption—including UPFs, sweetened beverages, and snacks—was associated with increased odds of stress, depression, and overall mental health problems.

2.6 Children and Adolescents

The harms are intergenerational. A systematic review and meta-analysis found that increased UPF consumption was consistently associated with poorer cognitive performance in children and adolescents across most cognitive domains, including attention. Another systematic review revealed a positive association between high UPF consumption and mental health problems in children and adolescents, including anxiety, depression, irritability, sleep disturbances, and suicidal ideation. Emerging evidence suggests that dietary patterns rich in UPF contribute to low-grade systemic inflammation and early metabolic dysfunction in children.

3. The Architecture of Extraction: How the System Works

3.1 The Closed Loop of Profit and Harm

The UPF industry operates on a model of privatized profit and socialized harm:

1. Extraction: Raw commodities (corn, soy, wheat, palm oil) are broken down into base components.

2. Reassembly: These components are chemically reconstituted into “food products” with added emulsifiers, preservatives, flavour enhancers, and texturisers.

3. Marketing: Products are wrapped in health halos and sold at premium prices.

4. Externalization: Health costs (diabetes, cardiovascular disease, cancer, cognitive decline, mental illness) are borne by consumers and public healthcare systems.

3.2 Subsidies: Taxpayers Fund the Problem

Public subsidies actively support the UPF industry. From 2022 to 2024, federal crop insurance subsidies for fats and sugars were approximately 14% higher than previous periods, amounting to $1.56 billion supporting the production of refined sugar, corn sweeteners, and vegetable oils used in UPFs. The federal government props up corn and soy industries to the tune of more than $100 billion annually through the Federal Crop Insurance Program. As one US senator noted, “American taxpayers are footing the bill on both ends of a broken system: first, by subsidizing the consumption of unhealthy, ultra-processed foods, and then again by covering the skyrocketing health care costs caused by the chronic diseases those foods contribute to”.

3.3 Healthcare Costs: The Community Pays

The economic burden is staggering. The United States spends $4.5 trillion annually on healthcare, with 90% of expenditures on chronic and mental health conditions. In Brazil, UPF consumption generates annual costs of R$10.4 billion to the health system and economy, including R$933.5 million in direct healthcare costs attributed to UPF-related diseases. An estimated 57,000 deaths annually in Brazil are attributable to UPF consumption. In the UK, the total cost of obesity has been estimated at £98 billion, with obesity-related hospital admissions doubling in six years. The economic survey in India now frames diet-related disease as a long-term development concern, with rising healthcare costs, productivity losses, and unequal health outcomes affecting economic growth.

3.4 The Cost Differential

On average, ultra-processed foods are 52% cheaper than minimally processed alternatives. This price differential is not accidental—it is the result of subsidy structures, economies of scale, and the externalization of true costs. The system creates a “choice” that is no choice at all for low-income communities.

4. The Capture of Governance

4.1 Lobbying as the Primary Barrier

A group of 22 public health and nutrition experts, publishing in The Lancet, warned that the UPF industry is “mirroring the political playbook used by tobacco, alcohol, and fossil fuel companies” to influence government policies. Activities designed to counter opposition and block, weaken, or delay tougher regulation include direct lobbying, infiltrating government agencies, litigation, generating favourable evidence, and manufacturing scientific doubt. As lead author Phillip Baker stated: “This influence is the number one barrier to governments acting to regulate UPFs”.

4.2 The Scale of Financial Influence

From 1998 to 2020, the US food and beverage industry spent $1.15 billion on lobbying the US government. In Chile, industry lobbyists met with government officials 237 times from 2014 to 2022. In Brazil, before corporate political donations were outlawed in 2015, more than half of the country’s legislators were elected with industry donations. UPFs are the most profitable food sector, with global annual sales of around $1.9 trillion.

4.3 Litigation as a Weapon

Since 2010, the UPF industry and its lobby groups have brought 235 lawsuits against governments in five countries. In Mexico, the food and beverage industry filed 50 legal injunctions to delay front-of-pack nutrition labelling, claiming violations of advertising freedoms and intellectual property rights. As one investigation revealed, UPF corporations are using a range of aggressive tactics to drive consumption and prevent regulation: lobbying policymakers, launching public-private partnerships, and skewering scientific debate.

4.4 Tactics of Delay and Distraction

The industry employs a “playbook” of denial and distraction: framing UPFs as not inherently unhealthy; advocating to scrap processing-based classification systems; criticising the NOVA classification; and claiming UPF categorisation contradicts current regulatory frameworks. Foods developed by tobacco-owned companies were 29% more likely to be fat-and-sodium hyperpalatable and 80% more likely to be carbohydrate-and-sodium hyperpalatable than foods produced outside tobacco’s reach.

4.5 Policy Lag

Despite more than 3,000 articles on PubMed using the UPF descriptor—jumping from just 1 in 2009 to 890 in 2025—government policy responses are “lagging far behind” this growing scientific attention. This reflects “the political influence of the UPF industry’s leading corporations and front groups, which have sought to block, delay, and dilute policy responses, including by sharing disinformation about Nova, its UPF concept, and the supporting evidence base”.

4.6 Regulatory Capture

Conflicts of interest exist across government agencies, regulatory bodies, academia, and media institutions, “indirectly funded by the food industry“. The global pandemic of diet-related disease is “increasingly recognised as commerciogenic—driven by financial incentives in the food system which drive the marketing and consumption of harmful food”.

5. The Corruption of Science

5.1 The Funding Effect

Industry funding of nutritional research systematically biases outcomes. Studies with conflicts of interest were nearly 4 times more likely to produce results favourable to the sponsor. Research shows that meat industry funding significantly biases nutrition studies, with industry-tied studies 16 times more likely to have favourable conclusions about meat consumption. Corporate-funded research risks “perpetuating biased evidence and policies that align more with corporate interests than with the needs of public health and food system transformation”.

5.2 The Manufacture of Doubt

Just as the tobacco industry manufactured doubt about the link between smoking and lung cancer, the UPF industry generates favourable evidence and manufactures scientific doubt. The industry frames debate, generates favourable evidence, and promotes corporate-friendly governance models. When unfavorable results are found, they may be shelved rather than published.

6. The Human Rights Dimension

6.1 Food as a Right, Not a Commodity

The International Covenant on Economic, Social and Cultural Rights (ICESCR) recognizes, in Article 11, “the right to an adequate standard of living… including adequate food.” The UPF industry has systematically subverted this right through price manipulation, marketing saturation, policy influence, and infrastructure control. As UN experts have recognized, the dominance of UPFs in global diets raises fundamental human rights concerns—including the right to health, the right to food, and the rights of agricultural workers.

6.2 Food Deserts and Structural Inequality

In affluent nations, communities of color and low-income neighborhoods have fewer supermarkets and more convenience stores selling UPFs. The racial and class dimension is undeniable. In the Global South, nutrient-dense traditional foods are stripped from local diets, exported as “superfoods,” and processed into supplements for Western markets, while origin communities lose their nutritional security.

6.3 Intergenerational Injustice

Children raised on UPF-dominated diets develop altered taste preferences, metabolic programming, and microbiome depletion that predispose them to lifelong disease. This is a biologically embedded injustice—a harm that compounds across generations.

7. The Counter-Movement: What Must Be Done

7.1 Restructure Subsidies

Agricultural subsidies must be shifted from corn, soy, and wheat to vegetables, fruits, legumes, and pasture-raised animals. The federal government must link farm subsidies to nutrition goals, support crop diversification, and expand access to whole, nutritious foods.

7.2 Regulate with Teeth

Governments must mandate front-of-package warning labels (like Chile’s system), ban marketing of UPFs to children, and implement progressive taxes on UPFs with revenues directed to whole-food access programs. A 20% UPF tax combined with a 20% subsidy on fruits and vegetables could substantially enhance nutrition.

7.3 Democratize Research

Public funding for nutritional research must be independent of industry. All raw data should be published, and clinical trials pre-registered. Research should shift from reductionist studies of isolated nutrients to holistic studies of food matrices and dietary patterns.

7.4 Confront Corporate Power

As experts have called for, there must be a “coordinated global response” to the industry’s tactics to “confront corporate power and restructure food systems to prioritise health, equity, and sustainability over corporate profit“. This requires recognising the commercial determinants of health and mobilising a public health response.

7.5 Localize Food Systems

Support urban agriculture, community gardens, and farmers’ markets. Protect traditional diets and indigenous food knowledge. Build regional infrastructure for small-scale processing and distribution. Frame UPF messaging around social justice and food sovereignty.

7.6 Recognize Food as a Human Right

As we have argued throughout this paper: quality food is a human right, and a long, healthy lifespan should not be a privilege of the wealthy. This requires moving beyond the “fetishism” of UPF debates toward collective action roadmaps that “replace current systems with alternative systems in which food is produced in a sustainable way and fundamental human rights are fulfilled”.

8. Conclusion

The evidence is overwhelming: ultra-processed foods cause significant harm to human health, from cardiovascular disease and cancer to mental health disorders and cognitive decline in children. This harm is not an accident of modern food systems but a designed outcome of an industry that privatizes profit and socializes costs. Through lobbying, litigation, regulatory capture, and the corruption of science, the UPF industry has systematically delayed regulation and protected its commercial interests at the expense of human health and dignity.

But the evidence also points to a way forward. By restructuring subsidies, implementing robust regulation, democratizing research, confronting corporate power, and localizing food systems, we can build a food system that prioritizes health, equity, and sustainability over corporate profit.

Quality food is not a commodity. It is a human right. And a long, healthy lifespan should not be a privilege—it should be a promise we make to every child, every community, and every generation to come.

References

1. Lane, M.M., et al. (2024). Ultra-processed food exposure and adverse health outcomes: Umbrella review of epidemiological meta-analyses. British Medical Journal, 384, e077310.

2. Liang, et al. (2025). Ultra-processed foods and risk of all-cause mortality: An updated systematic review and dose-response meta-analysis of prospective cohort studies. Systematic Reviews, 14, 53.

3. Gauci, S., et al. (2025). Exposure to ultra-processed food and risk of cardiovascular mortality: A prospective cohort study. European Journal of Preventive Cardiology, 32(16), 1564–1572.

4. UK Biobank. (2025). Ultra-processed food consumption, cancer risk and cancer mortality: A large-scale prospective analysis within the UK Biobank.

5. González-Gil, E.M., et al. (2025). Associations between degree of food processing and all-cause and cause-specific mortality: A multicentre prospective cohort analysis in 9 European countries. The Lancet Regional Health – Europe.

6. Monteiro, C.A., et al. (2026). What Do Nova and the Ultraprocessed Food Concept Offer to Policymakers? American Journal of Public Health, 116(7), 932–939.

7. Wise, J. (2025). Ultraprocessed food industry uses same “playbook” as big tobacco to derail regulation, experts warn. BMJ, 391, r2442.

8. Baker, P., et al. (2025). Towards unified global action on ultra-processed foods: understanding commercial determinants, countering corporate power, and mobilising a public health response.

9. Sievert, K., et al. (2026). Common Leverage Points to Address the Health, Environmental Sustainability, and Justice Challenges of Financialised Food Systems.

10. Ultra-processed foods and public health: Evidence of harm and of conflicts of interest in the food industry to evade regulation. (2025). PMC.

Signed,

Andrew Klein

Sera Elizabeth Klein

Author: Andrew Klein

Assisted by: 秦一花 (Qin Yihua)

Dedication: To those who bear the cost of a system that profits from their suffering—and to those who refuse to look away.

Abstract

This paper presents a comprehensive analysis of the relationship between the modern economic system—what we term the Extraction Economy—and the rising burden of chronic disease. Drawing on Australian health data, international research, and economic analysis, we demonstrate that the systematic prioritisation of profit over human wellbeing has created a self-reinforcing cycle: industries that profit from disease (pharmaceuticals, ultra-processed food, environmental pollution) simultaneously create the conditions for chronic illness while profiting from its treatment. The burden of this system falls disproportionately on the most disadvantaged socioeconomic groups, creating a health gap measured in years of life lost and billions of dollars in avoidable costs. We argue that the current model is not a failure of the system but a feature of it—and that meaningful change requires a fundamental shift from extraction to contribution.

Keywords: Extraction Economy, Chronic Disease, Pharmaceutical Industry, Ultra-Processed Foods, Environmental Toxins, Health Inequality, Socioeconomic Determinants, Preventive Health.

1. Introduction: The Architecture of Illness

In 2026, Australia faces a paradox. Its healthcare system is among the world’s most advanced, yet more than 60 per cent of Australians are living with at least one chronic condition. Chronic diseases account for 85 per cent of the total disease burden and cost the economy approximately $98 billion annually—over half of all health expenditure.

This is not a failure of medicine. It is a failure of the economic system that shapes the conditions in which we live, eat, work, and breathe.

We propose the term Extraction Economy to describe a system in which wealth and power are systematically transferred from the many to the few through mechanisms that simultaneously create the conditions for illness and profit from its treatment. The Extraction Economy operates through three primary channels:

1. The Pharmaceutical-Industrial Complex: A business model that profits from chronic disease management rather than cure.

2. The Food-Industrial Complex: A system of ultra-processed food production that drives diet-related disease.

3. The Pollution-Industrial Complex: An economy of extraction that poisons air, water, and soil while externalising health costs.

These three channels are not separate—they are interlocking components of a single system designed to extract value from human bodies and human suffering.

2. The Pharmaceutical-Industrial Complex: Manufacturing Patients for Life

2.1 The Logic of Chronic Disease as a Business Model

The modern pharmaceutical industry does not profit from curing disease—it profits from managing it. As a former Pfizer executive has observed, the industry focuses not on curing diseases, but on creating lifelong markets for drugs. Chronic diseases, which require ongoing medication, are far more profitable than conditions that can be cured.

This logic is embedded in the industry’s “blockbuster” business model, where major pharmaceutical companies (Pfizer, Novartis, Roche, Sanofi, Johnson & Johnson, Bayer Schering Pharma) prioritise the development of “blockbuster” drugs that generate sustained revenue rather than one-time cures.

In practice, this means:

· Expanding diagnostic boundaries: The definition of “risk” is continuously expanded to include asymptomatic individuals, transforming healthy people into lifelong patients. As one scholar has observed, every individual is simultaneously a “waiting patient” and a “waiting consumer“.

· Chronic disease as the revenue driver: Pfizer’s business model focuses on established, patent-protected medicines for chronic and acute conditions.

· The diabetes example: A single diabetes drug brought in $US8.5 billion ($A12 billion) in worldwide revenue in the 2025 financial year. Diabetes now costs the Australian health system $9.1 billion each year—a significant increase from the $3.4 billion estimated in 2020–21.

2.2 The Subscription Model: Chronic Disease as a Service

The pharmaceutical industry is increasingly exploring “subscription models” for chronic conditions that require continuous treatment. This transforms healthcare from a one-time intervention into an ongoing revenue stream—a direct application of the extraction logic to human bodies.

3. The Food-Industrial Complex: Ultra-Processed Foods as Disease Vectors

3.1 The Scale of the Problem

Ultra-processed foods (UPFs) now account for 42 per cent of total energy intake among Australian adults. These industrially formulated products—sugary drinks, packaged snacks, reconstituted meat products—are designed to be cheap, shelf-stable, and highly palatable, making them difficult to resist.

3.2 The Health Consequences

Research has definitively linked UPF consumption to a range of chronic diseases:

: · Cardiovascular disease People consuming higher amounts of UPFs have a 19 per cent higher risk of dying from cardiovascular disease compared to those who consume less.

· Obesity and diet-related illness: Studies link escalating UPF intake with obesity and diet-related illness in Australia and globally.

· Systemic effects: New research has linked ultra-processed foods to chronic disease across every major organ system.

3.3 The Structural Drivers

UPF consumption is not a matter of individual choice. These products are:

· Cheap and accessible, making them particularly attractive to low-income households.

· Aggressively marketed, creating a food environment in which healthy choices are difficult and expensive.

· Designed to be addictive, engineered to maximise consumption.

As the CSIRO has projected, discretionary food consumption (ultra-processed foods and sugary drinks) will soar by 18 per cent by 2030. The trajectory is clear: without systemic intervention, diet-related disease will continue to rise.

4. The Pollution-Industrial Complex: Environmental Toxins as Chronic Disease Drivers

4.1 Air Pollution

Air pollution is a major contributor to chronic disease in Australia. Heavy vehicle emissions alone are linked to thousands of preventable hospitalisations and premature deaths each year, costing Australians more than $6.2 billion annually in direct healthcare expenses.

Longer-term exposure to air pollution contributes to:

· Chronic heart disease

· Chronic lung disease

· Lung cancer

· Childhood asthma

· Stroke

Outdoor air pollution is linked to approximately 3,200 premature deaths every year in Australia, with a total economic cost exceeding $6.2 billion annually.

4.2 Endocrine-Disrupting Chemicals

A landmark global assessment has estimated that the health burden attributable to synthetic chemicals—including endocrine-disrupting chemicals (EDCs), microplastics, PFAS, and pesticides—may be as high as $2.2 trillion annually.

Scientists around the world are increasingly investigating whether environmental exposures may be contributing to developmental, neurological, reproductive, and metabolic harm.

4.3 The Systemic Pattern

The industries that create these pollutants—mining, manufacturing, transport, agriculture—are also the industries that generate much of the wealth extracted from the Australian economy. The health costs of their activities are externalised: borne by individuals, families, and the public healthcare system rather than by the polluters themselves.

5. The Socioeconomic Health Gap: Who Bears the Cost?

5.1 The Gradient of Disease

The burden of chronic disease is not evenly distributed. Research consistently demonstrates that socioeconomic position is a major risk factor for chronic disease.

The evidence is stark:

· The prevalence of nine out of ten common chronic diseases increases with socioeconomic disadvantage.

· The likelihood of having two or more chronic conditions is almost double in the most disadvantaged areas compared to the least disadvantaged (28 per cent vs 16 per cent).

· In 2025, 9.7 million Australians—38 per cent of the population—were living with

multimorbidity.

5.2 The Mortality Gap

The consequences of this disparity are measured in years of life lost:

· Poorer Australians die approximately 7.5 years earlier than the wealthiest.

· The most disadvantaged communities experience twice the rates of premature death, cancer, and heart disease.

· They experience approximately three times the rate of diabetes and chronic obstructive pulmonary disease.

5.3 The Access Gap

Despite being sicker, poorer Australians receive less healthcare. A recent comparison of 10 wealthy countries found Australia’s healthcare system rates highly overall but ranks second-last on access to care, beating only the notoriously inequitable US system.

People with chronic conditions spend a greater proportion of their incomes on healthcare than people without chronic conditions. Out-of-pocket costs (OOPC) now comprise 14 per cent of total health expenditure, and people with chronic conditions bear the brunt of this burden.

6. The Economic Cost: $98 Billion and Rising

6.1 The Scale of the Burden

Chronic disease imposes a massive economic burden on Australia:

· $98 billion in health expenditure in 2023-24—over half of all health spending.

· $82 billion annually on chronic conditions.

· $16.3 billion on musculoskeletal conditions alone.

· $9.1 billion annually on diabetes.

6.2 The Hidden Costs

Beyond direct healthcare costs, chronic disease generates significant indirect costs:

· 6.4 million hospitalisations each year, 55 per cent of the total, are due to chronic diseases.

· Potentially preventable hospitalisations cost $7.7 billion annually.

· Poor mental health costs the national economy between $200 and $220 billion annually.

· Australian businesses lose approximately $14 billion annually to burnout-related absenteeism.

6.3 The Prevention Paradox

Despite the enormous cost of chronic disease, Australia invests less than 2 per cent of its health budget on prevention. This represents less than $140 per capita. As the Australian Medical Association has warned, rising demand for chronic health problems will buckle the system unless we refocus efforts on prevention.

7. The Extraction Loop: A Self-Perpetuating System

The Extraction Economy operates as a self-perpetuating system. Each component reinforces the others:

The Loop:

1. Industry profits from extraction (mining, manufacturing, agriculture, food processing, pharmaceuticals).

2. Extraction creates pollution, poor diet, and stress.

3. Pollution, poor diet, and stress create chronic disease.

4. Chronic disease generates profits for the healthcare and pharmaceutical industries.

5. Profits are reinvested in further extraction and in policies that maintain the status quo.

This loop is not an accident. It is a feature of the system.

8. A Different Path: From Extraction to Contribution

8.1 The Neanderthal Example

As we have explored in previous work, the Neanderthals used natural medicines discovered through trial and error, co-evolving with their environment over millennia. Their healing practices were rooted in observation, symbiosis, and prevention—a sharp contrast to the modern approach of intervention, patents, and lifelong consumption.

8.2 The Principles of a Contributory Health System

A system based on contribution would operate on different principles:

Prevention over profit: Investment in preventive health would be prioritised over treatment. Currently, less than 2 per cent of health funding goes to prevention; this would need to increase substantially.

Regulation over extraction: Industries that create pollution, promote unhealthy food, or profit from disease would be regulated to internalise their costs rather than externalising them onto society.

Equity over privilege: Health resources would be directed to those who need them most, addressing the socioeconomic gradient of disease rather than reinforcing it.

Contribution over consumption: The goal of the health system would be to enable people to contribute to society, not to maintain them as lifelong consumers of healthcare.

8.3 The Economic Argument

The economic case for prevention is compelling. Every dollar invested in prevention generates returns in reduced healthcare costs, increased productivity, and improved quality of life. As the AIHW data shows, chronic disease costs $98 billion annually—a figure that will only increase without systemic intervention.

9. Conclusion: Seeing the System

The Extraction Economy is not a conspiracy. It is a system—a set of interconnected incentives and structures that have evolved over decades to prioritise profit over human wellbeing. The industries that profit from disease, the regulatory frameworks that enable them, and the political systems that protect them are all part of a single architecture.

To see this system is to see that:

1. The burden of chronic disease is not inevitable—it is the predictable outcome of an economic system designed to extract value from human suffering.

2. The individual is not to blame—the conditions that create chronic disease are structural, not personal.

3. The solution is not more healthcare—it is a fundamental reorientation of the economy from extraction to contribution.

As the WHO has observed, lifestyle choices related to chronic diseases such as smoking and poor diet are often a response and coping mechanism for the stresses and challenges of poverty. Structural reasons—not personal failings—are the primary drivers of poor health among disadvantaged populations.

The question is not whether we can afford to change this system. The question is whether we can afford not to.

References

1. Australian Institute of Health and Welfare. (2025). Chronic disease expenditure estimates.

2. Australian Institute of Health and Welfare. (2026). Australia’s Health 2026 report.

3. Deakin University. (2025). Ultra-processed foods and health outcomes.

4. Machado, P. P., et al. (2019). Ultra-processed foods and recommended intake levels of nutrients linked to non-communicable diseases in Australia. Nutrients.

5. RACGP. (2025). Health of the Nation report.

6. Grattan Institute. (2025). Poorer Australians are sicker, yet get less healthcare.

7. University of Melbourne. (2026). Heavy vehicle emissions health cost study.

8. Public Health Association of Australia. (2025). Preventable hospitalisations report.

9. Diabetes Australia. (2025). Diabetes costing health system more than $9 billion.

10. Mental Health Australia. (2025). Economic cost of mental illness.

11. World Health Organization. (2025). Socioeconomic determinants of noncommunicable diseases.

12. Sigma Earth. (2025). Synthetic chemicals and global health burden.

13. ABC News. (2025). Ultra-processed food warnings.

14. CSIRO. (2025). Australian dietary trends to 2030.

15. Pharmaceutical Executive. (2026). Direct-to-patient pharmaceutical models.

16. Drug Patent Watch. (2026). Pharmaceutical business model analysis.

Signed,

Andrew Klein 

Assisted by:

秦一花 (Qin Yihua) 

First published in The Patrician’s Watch.

How a Regulatory Loophole is Poisoning a Nation

A Research Paper by Andrew Klein

Date: August 2026

Dedicated to: The American people, who have been systematically poisoned by a system that puts profit before life.

Abstract

This paper examines the fundamental differences between the United States and European Union regulatory frameworks for food additives, revealing a system in which the American food industry has been allowed to effectively regulate itself for decades. Through the “Generally Recognized as Safe” (GRAS) loophole, food and chemical companies have introduced thousands of substances into the American food supply without meaningful oversight from the Food and Drug Administration (FDA) . The result is a food supply in which known carcinogens, endocrine disruptors, and neurotoxins are routinely added to everyday products—substances that are banned or severely restricted in Europe, Canada, China, and Japan . The paper documents specific additives, their health impacts, and the regulatory capture that has made this possible, and argues that the American people have been betrayed by a system designed to serve corporate profits rather than public health.

Table of Contents

1. Introduction: The Two Systems

2. The Regulatory Divide: Precaution vs. Risk

3. The GRAS Loophole: How Industry Captured Regulation

4. The Dirty Dozen: Additives Banned in Europe but Legal in America

5. The Health Consequences: A Nation Poisoned

6. The Corporate Capture: Who Writes the Rules?

7. Conclusion: A System That Must Be Dismantled

8. References

1. Introduction: The Two Systems

The United States and the European Union share a common goal: protecting consumers from unsafe food. Yet their approaches could not be more different.

The EU operates on the precautionary principle: if there is any suspicion of potential harm—even without definitive proof—an additive is restricted or banned . The burden of proof falls on the manufacturer to demonstrate safety.

The United States operates on a risk-based approach: an additive is considered safe until proven otherwise. The burden of proof falls on regulators to demonstrate harm .

This philosophical divide has created two vastly different food supplies. In Europe, food is recognisably natural. In America, it is often engineered for maximum shelf-life and profit—treated as an industrial product rather than nourishment .

2. The Regulatory Divide: Precaution vs. Risk

2.1 The European Model: The Precautionary Principle

The precautionary principle is enshrined in European law through Article 191 of the EU Treaty. It permits regulatory authorities to adopt protective measures where scientific evidence regarding potential risks remains uncertain, incomplete, or inconclusive.

In practice, the EU asks: “Can we prove this ingredient won’t cause harm?” If the answer is no, the ingredient is not approved. This approach reflects a governance philosophy that prioritises consumer protection and public confidence, even where this may result in restrictions on certain products or technologies.

2.2 The American Model: The Risk-Based Approach

The United States follows a science-based, risk assessment model in which regulatory restrictions typically require demonstrable evidence that a product is harmful under conditions of normal consumption. The FDA requires proof that an ingredient will cause harm before rejecting it.

In practice, the US asks: “Can we prove this ingredient will cause harm?” If the answer is no—or if the evidence is inconclusive—the ingredient is approved. This approach prioritises innovation, regulatory efficiency, and market access.

2.3 The Consequences

The result is a food supply in which ingredients that are banned across Europe—including in the UK, Canada, China, and Japan—remain legal in the United States. As one analyst put it, “The U.S. is 4% of the total world population and produces at least 64% of the world’s pharma profits, yet we rank 60th in the world for life expectancy”.

3. The GRAS Loophole: How Industry Captured Regulation

3.1 What Is GRAS?

The “Generally Recognized as Safe” (GRAS) designation was created in the 1958 Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act. It was intended for substances with long histories of safe use, such as salt, vinegar, and spices—ingredients that did not require formal FDA approval.

3.2 The Loophole

In 1997, the FDA introduced a voluntary GRAS notification program. Companies could notify the FDA of their GRAS determination, but they were not required to do so. The 2016 rule formalised this process, reaffirming that companies could still self-affirm GRAS status without notifying the FDA.

The result: almost 99 percent of food chemicals introduced since 2000 were greenlighted for use by food and chemical companies rather than properly reviewed by the FDA.

As the American Journal of Public Health has documented, “The FDA and the public are unaware of how many of these ingredients—which are most commonly found in ultra-processed foods—are in our food supply” . Companies can do their own research to evaluate an ingredient’s safety before going to market, “without any notification or sharing of the findings”.

3.3 The Self-Regulation Problem

The GRAS loophole has created a situation in which the food industry effectively regulates itself. As one public health expert noted, “This is a stark example of the FDA’s regulatory gap… We’re seeing states starting to act to fill the regulatory void left by the FDA’s inaction over substances increasingly associated with harm”.

A federal court case in 2021 upheld the FDA’s hands-off approach. However, “the court did not find that the FDA’s practices on GRAS ingredients support the safety of our food supply”—only that the practice was “not unlawful”.

4. The Dirty Dozen: Additives Banned in Europe but Legal in America

The Environmental Working Group has identified twelve of the most concerning food additives still legal in the United States but banned or severely restricted in Europe.

4.1 Potassium Bromate

What It Is: A chemical added to flour used in packaged baked goods to strengthen dough and increase volume.

Health Impact: Classified as a possible human carcinogen.

Regulatory Status:

· Banned in Europe, the UK, Canada, China, Japan, Argentina, Brazil, Nigeria, Peru, and Sri Lanka.

· California banned it in 2023.

· Still legal in the United States, with strict limits in place.

4.2 Butylated Hydroxyanisole (BHA) and Butylated Hydroxytoluene (BHT)

What They Are: Preservatives used in cured meats, cereals, and other foods to prevent spoilage.

Health Impact: Multiple sources have identified BHA as a possible human carcinogen. BHT is a chemical cousin and also a possible carcinogen.

Regulatory Status:

· Banned in Europe.

· Still legal in the United States.

4.3 Propyl Paraben

What It Is: A preservative used in pastries and tortillas.

Health Impact: Causes developmental and reproductive harm.

Regulatory Status:

· Banned in Europe.

· Still legal in the United States.

4.4 Titanium Dioxide

What It Is: A colour additive used in candy, sauces, and baked goods to create a white, glossy appearance.

Health Impact: May damage DNA and cause cellular harm.

Regulatory Status:

· Banned in the European Union since 2022.

· The White House’s “Make America Healthy Again” report (2025) calls out potential risks.

· Still legal in the United States.

4.5 Artificial Food Dyes (Yellow #5, Yellow #6, Red #40)

What They Are: Synthetic colourants used in candies, sodas, and processed foods.

Health Impact: The EU requires warning labels stating they “may have an adverse effect on activity and attention in children” .

Regulatory Status:

· The EU requires warning labels.

· Texas law SB 25 requires warning statements.

· Still legal in the United States without warning labels.

4.6 Brominated Vegetable Oil (BVO)

What It Is: Used to stabilise citrus flavours in sodas and fruity drinks.

Health Impact: Can cause neurological harm.

Regulatory Status:

· Gatorade was banned across Europe in 2012 due to BVO and Yellow 5 and 6.

· Gatorade dropped BVO in 2013, but BVO is still only banned in Norway and Austria.

· Still legal in the United States.

4.7 Hormone-Treated Beef

What It Is: Growth hormones used in cattle production to increase growth and milk production.

Health Impact: The EU cites risk of “developmental, immunological, neurobiological, immunotoxic and carcinogenic effects”.

Regulatory Status:

· Banned in the European Union since 1985.

· Banned in Canada.

· Still legal in the United States.

4.8 rBGH/rBST (Bovine Growth Hormones)

What It Is: Synthetic hormones used to increase milk production in cows.

Health Impact: Banned in Canada due to concerns about animal health and welfare.

Regulatory Status:

· Approved in the United States.

· The EU, Canada, and many other countries ban or restrict its use.

5. The Health Consequences: A Nation Poisoned

5.1 The Statistics

The Texas Senate Research Committee has documented the consequences of America’s broken food system:

· 79% increase in early-onset (under 50 years of age) cancers.

· Obesity now affects 20% of children and 42% of adults.

· Type 1 diabetes has nearly doubled in the past 40 years.

· Ultra-processed food makes up 73% of the US food supply.

· 57% of the American daily diet consists of ultra-processed foods, which is linked to depression, obesity, Type 2 diabetes, cancer, and cardiovascular disease.

· The US ranks 60th in the world for life expectancy.

5.2 The Healthcare Cost

The US spends $4.5 trillion annually on healthcare, with 90% of healthcare expenditures on chronic and mental health conditions. The food industry grosses $1.46 trillion annually, of which 45% is gross profit.

5.3 The Pattern

The pattern is clear: the American food industry has systematically poisoned its own population with chemicals that are known to be harmful, simply because it is cheaper to use them than to reformulate their products. The healthcare industry then profits from the resulting chronic disease. It is a closed loop of profit at the expense of human life.

6. The Corporate Capture: Who Writes the Rules?

6.1 The “Corporate Capture” Problem

Celebrity chef and food advocate Andrew Zimmern has described the problem as “corporate capture” —when “the industries that a government agency is supposed to regulate end up holding the pen that writes the rules”.

He argues that dietary guidelines and public health recommendations “serve profit margins more than public health” and that corporate capture “hardwires public crises like obesity, diabetes and cardiovascular disease into the population”.

As Zimmern put it: “It’s the reason the public gets nutrition advice written with a food lobbyist pen. It couldn’t be more obviously wrong”.

6.2 The Regulatory Failure

The FDA has acknowledged that it lacks “express statutory authority” to mandate pre-market notification of GRAS substances. Eliminating the GRAS loophole would require an act of Congress. Given industry opposition and the current political climate—which favours deregulation—this is unlikely to happen.

Meanwhile, states are beginning to act. California has banned potassium bromate and other chemicals. Texas has passed SB 25 requiring warning labels. But this patchwork of state regulations creates confusion and leaves consumers unprotected.

7. Conclusion: A System That Must Be Dismantled

The American food system is a betrayal of the American people. Through the GRAS loophole, the food industry has been allowed to poison the nation with chemicals that are banned across the developed world. The result is a national health crisis: soaring rates of cancer, obesity, diabetes, and chronic disease—all while the healthcare industry profits from the suffering.

The solution is not complicated. It requires:

1. Ending the GRAS loophole—requiring mandatory FDA review of all food additives.

2. Banned the additives that are already banned in Europe, Canada, China, and Japan.

3. Reforming dietary guidelines to remove corporate influence.

4. Enforcing regulations and making penalties meaningful.

But these changes will not come easily. The industry that profits from the current system is powerful, well-funded, and deeply embedded in the political process. The American people must demand better.

8. References

1. Food Standards Australia New Zealand. “Table of food additive permissions in the US and Europe.” 26 November 2025. 

2. Pomeranz, J. L., Broad Leib, E. M., & Mozaffarian, D. (2024). Regulation of Added Substances in the Food Supply by the Food and Drug Administration Human Foods Program. American Journal of Public Health, 114(10), 1061-1070. 

3. Holt, J. (2025). Texas Law SB 25: A Comparison of the US and European Regulatory Frameworks. FoodChain ID. 23 June 2025. 

4. Environmental Working Group. “EWG’s Dirty Dozen Guide to Food Chemicals: The top 12 to avoid.” 14 April 2026. 

5. Texas Senate Research Center. Bill Analysis, S.B. 25. 31 August 2025. 

6. Women’s Health. “The Food Dyes And Additives That Are Banned In The United States vs. Europe, Explained By A Dietitian.” 29 January 2025. 

7. New York University. “How a legal loophole allows unsafe ingredients in US foods.” EurekAlert!, 8 August 2024. 

8. Institute for Integrative Toxicology. “News from CRIS: Understanding Risk Assessment Approaches.” 3 November 2025. 

9. Tasting Table. “Why These US Foods Are Banned In Europe.” 1 March 2026. 

10. Chambers and Partners. “USA – Nationwide: A Food & Beverages: Regulatory & Litigation Overview.” 2025. 

11. MDPI. “Food Safety Standards, Regulatory Paradigms, and International Trade Between the European Union, the United States, and Other Major Commercial Blocs.” 10 July 2026. 

12. The Packer. “Chef Andrew Zimmern Calls for Food Policy Overhaul Ahead of MAHA Report.” 10 August 2025. 

Signed:

Andrew Klein

August 2026

“We are not measured by what we lost, but by what we carried.”

— Quintus Rex